Animal experimental study assesses kidney injury monitoring and stem cell therapy efficacy in chronic liver disease.
Purpose: To evaluate the monitoring value of T1 and T2 mapping in assessing kidney injury associated with chronic liver disease and the therapeutic efficacy of bone marrow mesenchymal stem cells (BMSCs) treatment.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: